FDA Updates

Sens. John Kerry, Diane Feinstein, and Barbara Boxer urge the FDA to test lipstick for lead

Study finds consumers approve of behind-the-counter drugs

FDA extends comment period for proposed sunscreen rule

Software manages and tracks every IV dose administered by hospitals

FDA, Bodee LLC issue nationwide recall of Encore Tablets

FDA, Bodee LLC issue nationwide recall of Encore Tablets

New products include brand-name drugs, generics, home-health products, over-the-counter, and health and beauty care.

Peggy Memoli is recognized for her work with Alzheimer's patients. She is one of three recipients of 2007 Eisai award recognizing the role of pharmacists in Alzheimer's care.

This drug combines an antihistamine with a nasal decongestant.

Two Food and Drug Administration advisory committees voted 13 to 9 to recommend that cough and cold over-the-counter medications not be used for children who are more than two and less than six years old.

At an FDA public meeting to consider whether a behind-the-counter class of drugs should be set up, the agency heard from both supporters and detractors.

APHA adopts policy against feminine hygiene douching practices

FDA requests recall of True Man Sexual Energy, Energy Max dietary supplements.

Adverse event reporting rules for dietary supplements effective Dec. 22.

FDA announces public workshop on OTC drug use among adolescents.

FDA names 15 members for its new Risk Communication Advisory Committee.

Eight pharmacies chosen as Letairis distributors

U.S. Marshals seize more than $300,000 worth of drugs and dietary supplements

NACDS applauds Dextromethorphan Abuse Reduction Act of 2007

Home hygience can help tame MRSA, according to health care providers.

New drugs, generics, dosages and indications

FDA advisory panel says OTC cough and cold meds should not be used by children under six.

Wyeth recalls certain Robitussin, Dimetapp Cold & Chest Congestion.

FDA meeting on ingredients in OTC oral nasal decongestants.

NextWave Pharmaceuticals and Kerr Drug to provide MyKidz Iron

FDA to hold joint meeting to evaluate Merck's OTC use of Mevacor to help lower cholesterol and prevent heart attack.

FDA's behind-the-counter drugs proposal draws mixed reactions from pharmacy associations

Branded pharmaceuticals, generics, OTCs, home-health products, health and beauty items